Attached files

file filename
10-K/A - FORM 10-K (AMENDMENT NO. 1) - EyePoint Pharmaceuticals, Inc.d273854d10ka.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - EyePoint Pharmaceuticals, Inc.d273854dex311.htm
EX-10.13 - AMENDED AND RESTATED COLLABORATIVE RESEARCH AND LICENSE AGREEMENT - EyePoint Pharmaceuticals, Inc.d273854dex1013.htm

Exhibit 31.2

Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.

CERTIFICATIONS

I, Leonard S. Ross, certify that:

 

1. I have reviewed this Annual Report on Form 10-K/A (Amendment No. 1) of PSIVIDA CORP.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Date: December 27, 2011

 

  /S/    LEONARD S. ROSS        
Name:   Leonard S. Ross
Title:  

Vice President, Finance

(Principal Financial and Accounting Officer)